Actively Recruiting
EMG Biofeedback Training to Improve Balance in Individuals with Multiple Sclerosis
Led by McMaster University · Updated on 2024-12-03
46
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
M
McMaster University
Lead Sponsor
M
Multiple Sclerosis Society of Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test the impact of a novel dual-task EMG Biofeedback training method for improving balance in individuals living with multiple sclerosis. The main question\[s\] it aims to answer are: * Does dual-task EMG biofeedback training deliver lasting balance benefits up to 3 months following the intervention? * Are the benefits greater than those for participation in traditional balance training exercises? * Do the benefits vary with the severity of disability? Participants will receive either EMG Biofeedback (EMG-BF) training or traditional balance exercise (BAL-EX) training. Both treatments involve three 30-minute sessions of the training every week for 6 weeks (18 sessions). During the sessions, participants in the EMG-BF treatment group will perform targeted exercises using feedback from adhesive (sticker) sensors on their arms and legs. Participants in the BAL-EX treatment group will following an instructor through balance training movements that are traditionally prescribed by physiotherapists to improve balance. Measurements will be taken at the beginning of the study, after six weeks of training, and three months after the end of training. Researchers will compare the groups to see if balance and related outcomes are improved more by 6-weeks of EMG-BF training than BAL-EX.
CONDITIONS
Official Title
EMG Biofeedback Training to Improve Balance in Individuals with Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-80 years with a formal diagnosis of MS
- Able to walk and report problems with walking and/or balance
- Stable MS with no relapses in the last 3 months
- Agree to keep medication doses unchanged during the study, including injections and oral drugs
- Agree to maintain the same frequency, duration, and intensity of physical or alternative therapies during the trial
You will not qualify if you...
- Unable to follow instructions due to cognitive or language difficulties
- Visual problems that prevent meaningful interaction with the training interface
- Unable to keep medication stable during the study
- Unable to maintain physical or alternative therapy routines outside the trial during the study
- Received Botox treatment within 3 months before starting the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
McMaster University
Hamilton, Ontario, Canada, L8S4L1
Actively Recruiting
Research Team
A
Aimee J Nelson, PhD
CONTACT
S
Stephen L Toepp, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here